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Liver X receptors (LXR and -) are liposensors
that exert their metabolic effects by orchestrating
the expression of macrophage genes involved in
lipid metabolism and inflammation. LXRs are also
expressed in other tissues, including skin, where
their natural oxysterol ligands induce keratinocyte
differentiation and improve epidermal barrier func-
tion. To extend the potential use of LXR ligands to
dermatological indications, we explored the possi-
bility of using LXR as a target for skin aging. We
demonstrate that LXR signaling is down-regulated
in cell-based models of photoaging, i.e. UV-acti-
vated keratinocytes and TNF-activated dermal fi-
broblasts. We show that a synthetic LXR ligand
inhibits the expression of cytokines and metallo-
proteinases in these in vitro models, thus indicat-
ing its potential in decreasing cutaneous inflam-
mation associated with the etiology of photoaging.
Furthermore, a synthetic LXR ligand induces the
expression of differentiation markers, ceramide
biosynthesis enzymes, and lipid synthesis and
transport genes in keratinocytes. Remarkably,
LXR-null mouse skin showed some of the molec-
ular defects that are observed in chronologically
aged human skin. Finally, we demonstrate that a
synthetic LXR agonist inhibits UV-induced photo-
damage and skin wrinkle formation in a murine
model of photoaging. Therefore, the ability of an
LXR ligand to modulate multiple pathways un-
derlying the etiology of skin aging suggests that
LXR is a novel target for developing potential
therapeutics for photoaging and chronological
skin aging indications. (Molecular Endocrinology
22: 2407–2419, 2008)
SKIN AGING IS a result of the combination of twobiological processes, chronological aging and
photoaging. Chronological aging represents the phys-
iological changes in skin that occur over time, resulting
in a dry, thin skin that has fine wrinkles and is easily
injured. Photoaging results from the damaging effects
of solar UV radiation, causing the skin to age prema-
turely, and is characterized by wrinkles, laxity, and
dryness (1–3). Some of the molecular mechanisms
underlying skin aging have been uncovered. The pro-
cess of photoaging involves epidermal keratinocytes,
dermal fibroblasts, and infiltrating neutrophils. UV ex-
posure induces activator protein 1 (AP-1) and nuclear
factor-B (NF-B) activation in the skin, leading to the
expression of matrix metalloproteinases (MMPs) and
cytokines in keratinocytes (4). Cytokines in turn acti-
vate dermal fibroblasts to secrete MMPs, which dam-
age the extracellular matrix (5). Cytokines and other
chemotactic factors also recruit neutrophilic granulo-
cytes to the dermis, which secrete elastase and
MMPs, thus contributing to UV-mediated dermal ex-
tracellular matrix degradation (3). Repeated exposure
to UV radiation results in the accumulation of incom-
pletely degraded collagen in the dermis, leading to
wrinkle formation. Chronological aging is character-
ized by cellular senescence, leading to decreased ker-
atinocyte proliferation, improper terminal differentia-
tion, reduced neutral lipid synthesis, and reduced
collagen synthesis (6–11). Prostaglandin E2 (PGE2),
MMP production, and oxidative damage are also in-
creased (10, 12–14). Agents that inhibit one or more of
these processes are candidates for a therapeutic tar-
get for skin aging.
Liver X receptors (LXR/NR1H3 and LXR/NR1H2)
are ligand-dependent transcription factors whose
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agonists induce the expression of genes involved in
cholesterol efflux and transport and decrease the ex-
pression of inflammatory mediators in macrophages
and microglia (15–17). These activities underlie the
atheroprotective and anti-Alzheimer’s potential of
LXR ligands (17–19). In addition, LXR agonists dis-
play potent antiinflammatory activities and have
shown therapeutic efficacy in murine models of der-
matitis and rheumatoid arthritis (20, 21). In the skin,
LXRs are expressed in keratinocytes (LXR and - in
human and LXR in murine keratinocytes), and their
natural ligands have been shown to induce keratin-
ocyte differentiation (21, 22) and improve epidermal
barrier function (23). The synthetic ligand (T1317)
used in this study (24) has been shown to induce
ABCA1 expression in human keratinocytes and mu-
rine skin (25). It also induced the expression of AP1
protein, Fra-1, in keratinocytes (26) and stimulated
epidermal lipid synthesis in murine skin (23). Based
on these properties, we hypothesized that an LXR
ligand could interfere with various steps involved in
the etiology of both photoaging and chronological
skin aging. Therefore, we examined the effects of a
synthetic LXR ligand in models of skin aging using
keratinocytes and fibroblasts as well as in a murine
model of photoaging. Our observations indicate that
LXR ligands could provide a new category of ther-
apeutic agents for both photoaging and chronolog-
ical skin aging.
RESULTS
LXR Signaling in Cell-Based Systems
of Photoaging
LXR was the predominant isoform in normal human
epidermal keratinocytes (NHEKs), whereas both LXR
and - were equally expressed in dermal HFF fibro-
blasts (Fig. 1A). For comparison purposes, the expres-
sion of vitamin D receptor (VDR) in both NHEKs and
dermal fibroblasts is also shown (Fig. 1A). We next
examined the expression of LXR and - in various
human tissues by in silico data mining of an internally
derived database of Affymetrix Human Genome U133
Plus 2.0 microarray data. The collection consisted of
approximately 8000 individual samples representing
33 distinct tissues. As shown in Fig. 1, B and C, both
LXR and - were expressed in human skin (black
bars) and a number of other tissues. Notably, LXR
was the predominant isotype expressed in human
white blood cells and neutrophils (Fig. 1C; gray bars),
a cell type that is implicated in photoaging (3). Be-
cause UV exposure of epidermal keratinocytes and
cytokine activation of dermal fibroblasts are postu-
lated to be the initial triggering events in photoaging
(5), status of the LXR signaling pathway was studied
after these treatments. In NHEKs, UV radiation inhib-
ited the expression of known LXR-responsive genes
while at the same time induced the expression of
MMP1 (Fig. 1D). Similarly, TNF treatment of normal
human dermal fibroblasts (NHDFs) and a dermal fibro-
blast cell line (BJ) also decreased the expression of the
known LXR-responsive genes (Fig. 1, E and F). In
addition, TNF treatment induced the expression of
MMP1, ADMTS4, and prostaglandin E synthase (PT-
GES) in fibroblasts (Fig. 1, E and F). These results
indicate that the UV and cytokine activation of skin
cells not only induces the expression of inflammation-
related MMP1, ADAMTS4, and PTGES genes but also
represses the expression of classical LXR-responsive
genes.
Identification of LXR as a Target for Photoaging
To evaluate LXR as a target for photoaging, NHEKs
were treated with vehicle or a synthetic LXR ligand
(T1317) (24) with or without UV radiation (8 mJ/cm2).
T1317 was also tested for nuclear receptor (NR) spec-
ificity in a biochemical NR-cofactor peptide recruit-
ment assay that provides a readout of the binding of
the compound to the NR ligand-binding domain (LBD).
In this surrogate ligand binding assay, T1317 recruited
cofactor peptides to LXR, LXR, and pregnane X
receptor (PXR) LBD proteins with EC50 (concentration
of the ligand required for 50% increase in NR-cofactor
peptide interaction) values of 75, 21, and 7 nM, respec-
tively. T1317 was not active (EC50 50 M) in recruit-
ing cofactor peptides to androgen receptor (AR),
constitutive androstane receptor (CAR), estrogen re-
ceptor- (ER), ER, glucocorticoid receptor, FXR,
ER-related receptor- (ERR-), peroxisome prolifera-
tor-activated receptor- (PPAR), PPAR, PPAR,
progesterone receptor (PR), retinoic acid receptor-
(RAR), RAR, RAR, retinoid X receptor- (RXR),
RXR, thyroid hormone receptor- (TR), TR, and
VDR LBD proteins in this ligand-sensing assay. Be-
cause pregnane X receptor (PXR) is not expressed in
skin, keratinocytes, and dermal fibroblasts (data not
shown), T1317 could function only through LXRs in
skin systems. UV exposure decreased the expression
of LXR in keratinocytes, which was restored by
T1317 treatment (Fig. 2A). In NHEKs, UV-induced ex-
pression of TNF, IL-8, and MMP3 was significantly
down-regulated by T1317 (Fig. 2A). Interestingly, sig-
nificant induction of tissue inhibitor of metalloprotein-
ases (TIMP)-1 expression by the LXR ligand was ob-
served in both mock-exposed and UV-exposed
keratinocytes (Fig. 2A). Because UV-exposed keratin-
ocyte cytokines activate dermal fibroblasts by a para-
crine pathway in photoaging (5), we next examined the
effect of T1317 on cytokine/MMP expression in TNF-
activated fibroblasts. TNF augmented the expression
of MMP1 and MMP3 in BJ fibroblasts, which was
significantly inhibited after treatment with the LXR li-
gand (Fig. 2B). As observed in keratinocytes, fibro-
blasts also showed the induction of TIMP-1 expres-
sion by the LXR ligand in TNF-treated cells (Fig. 2B).
In addition to MMP1 and -3, the LXR ligand also de-
creased the expression of cyclooxygenase-2 (COX-2)
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and cytokines IL-8, IL-6, and IL-1 in TNF-activated
NHDFs (Fig. 2C). Similar results were obtained in
TNF-activated BJ and HFF cells lines (data not
shown). To ascertain the receptor specificity of T1317
effects on cytokine/MMP expression, mouse LXR
wild-type (WT) or knockout (KO) dermal fibroblasts
were used. Cultured LXR WT fibroblasts showed high
expression levels of Mmp13 (mouse equivalent of hu-
man MMP1), Mmp3, and Il1. T1317 significantly de-
creased the expression of these cytokines in WT but
not LXR KO fibroblasts, thus indicating that T1317
mediates negative regulation of cytokine/MMP ex-
pression through the LXR signaling pathway (Fig.
2D). UV exposure of hairless mice results in epidermal
hyperplasia, wrinkle formation, and increased expres-
sion of MMP2 and MMP9 (27), and UV also induces
these MMPs in human skin (4). Because the expres-
sion of these MMPs was low in cultured human and
murine fibroblasts with or without TNF activation,
their expression was analyzed in LXR KO and WT
mouse skin. As shown in Fig. 2E, the expression of
Mmp2 and Mmp9 was significantly increased in LXR
KO mouse skin, thus indicating that the presence of
LXR in skin enforces a repression on the expression
of these metalloproteinases. These results in UV-ex-
posed keratinocytes, TNF-activated fibroblasts, and
LXR KO fibroblasts and skin samples suggest that
LXR is a novel target for photoaging.
LXR-Mediated Regulation of Keratinocyte
Differentiation Markers
Chronological aging involves defects in keratinocyte


























































































































































































































































































Fig. 1. Receptor Expression and the Status of LXR Signaling in Cell-Based Models of Photoaging
A, Relative gene expression levels of LXR, LXR, and VDR in NHEK (white bars) and HFF (black bars) cells. The
expression of these nuclear receptors was measured by real time quantitative PCR; results were normalized to 18S RNA.
B and C, Relative expression of LXR (B) and LXR (C) in various human tissues as analyzed from an internal database
derived from Affymetrix Human Genome U133 2.0 Plus data. Black bars represent relative in silico expression in skin, and
gray bars show the expression of LXR in neutrophils and white blood cells. D, The relative expression level of known
LXR-regulated genes and MMP1 was compared in NHEKs with (black bars) or without (white bars) UV exposure (8 mJ/cm2)
by custom-made TLDAs. E, The relative expression of known LXR-regulated genes MMP1, ADAMTS4, and PTGES was
compared in NHDFs with (black bars) or without (white bars) TNF (1 ng/ml) treatment by TLDAs used in D. F, The relative
expression level of known LXR-regulated genes MMP1, ADAMTS4, and PTGES was compared in BJ fibroblasts with (black
bars) or without (white bars) TNF (1 ng/ml) treatment by TLDAs. *, P  0.01; **, P  0.05 vs. vehicle control as determined
by Student’s t test.
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lipid synthesis (7–9, 11, 28, 29). Here, we demonstrate
that T1317 induced the expression of the keratinocyte
early differentiation marker involucrin (IVL) as well as
late differentiation markers loricrin (LOR), filaggrin
(FLG), and transglutaminase 1 (TGM1) in NHEKs (Fig.
3A). The LXR ligand may induce the expression of
these genes indirectly by augmenting keratinocyte dif-
ferentiation via increased AP-1 activity because it in-
creased the expression of IVL via its upstream AP-1
motif (26, 30–33). We next examined the effect of
LXR ablation on the expression of these differentia-
tion markers and Tgm family members. As shown in
Fig. 3B, the expression of Ivl, Tgm3, and Tgm6 was
down-regulated in LXR KO mouse skin, thus indi-
cating that Ivl and these Tgm family members are
indeed LXR-responsive genes. The LXR ligand also
induced the expression of Tgm1 (Fig. 3C), Tgm3,
and Tgm6 (Fig. 3D) in LXR WT but not KO cultured
keratinocytes, indicating that T1317 mediated its
effects on keratinocyte differentiation markers spe-
cifically through LXR.
LXR-Mediated Regulation of Lipid Synthesis
and Transport Genes in Keratinocytes
A comparison of chronologically aged and young skin
shows a significant decrease in total lipid content with
aging (7, 28, 29). Because lipids mediate epidermal
barrier homeostasis, we next examined the effect of
T1317 on the expression of genes involved in fatty acid
synthesis and lipid transport. The LXR ligand induced
the expression of genes involved in fatty acid synthe-
sis, namely SREBF1, SREBF2, FASN, and SCD, and




























































































































* * * *
*
*
























































Fig. 2. The LXR Ligand Antagonizes UV and Cytokine-Mediated Gene Expression in Skin Cells
A, T1317 inhibits UV activation of keratinocytes. Relative gene expression levels of LXR, TNF, IL-8, MMP3, and TIMP1
in NHEKs with and without UV (8 mJ/cm2) radiation, in the presence and absence of the synthetic LXR ligand T1317 (1 M).
Mean expression of these genes was determined by real-time RT-PCR, and the results were normalized to 18S RNA
expression. B, T1317 inhibits cytokine and MMP expression in TNF-activated dermal fibroblasts. Relative expression levels
of MMP1, MMP3, and TIMP1 in BJ fibroblasts with or without TNF (1 ng/ml) in the presence (black bars) or absence (white
bars) of T1317 (1 M) is shown. C, The effect of T1317 on relative gene expression levels of MMP1, MMP3, cytokines (IL-1,
IL-6, and IL-8) and COX-2 in TNF-treated (1 ng/ml) NHDFs are presented. The relative gene expression levels for these
MMP, cytokine, and COX-2 genes were measured using a custom-made TLDA, and the results were normalized to 18S RNA
expression. D, T1317 mediates its effects via LXR in dermal fibroblasts. The relative gene expression levels of Mmp3,
Mmp13, and Il1 in ex vivo cultured LXR WT and KO mice dermal fibroblasts with or without T1317 (1 M) treatment are
presented. E, Mmp2 and Mmp9 expression in LXR-null skin. The mRNA expression of Mmp2 and Mmp9 was examined by
real-time RT-PCR in LXR WT (white bars) and KO (black bars) skin samples. *, P  0.01; **, P  0.05 vs. vehicle or WT
control as determined by Student’s t test.
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port, namely APOE, APOD, ABCG1, ABCA1, ABCA12,
ABCA2, and ABCA13 (Fig. 4A). ABCA2, ABCA12, and
ABCA13 are newly identified LXR-responsive genes,
and the responsiveness of ABCA12 has only recently
been described (34). Furthermore, T1317 increased
the expression of Abcg1 and Scd1 in LXR WT but not
KO keratinocytes (Fig. 4B), indicating that the ligand
mediated its effects through LXR.
Ceramides, one of the major lipids in differentiated
keratinocytes, play a pivotal role in skin barrier forma-
tion (7, 28), and their content declines due to reduced
ceramide synthase (LASS) and sphingomyelin phos-
phodiesterase (SMPD) activities in chronologically
aged skin (29). Serine palmitoyltransferase (SPTLC)
catalyzes the formation of sphinganine from serine and
palmitoyl-CoA (Fig. 4C). Ceramide is produced either
from sphinganine or sphingomyelin by LASS or SMPD
activities (Fig. 4C). Here, we demonstrate that T1317
induced the expression of LASS4 and SMPD2 in both
mock-exposed and UV-exposed NHEKs, whereas its
effect on SMPDL3B was observed only in UV-exposed
cells (Fig. 4D). Note that UV significantly decreased the
expression of LASS4 and SMPD2, and the LXR ligand
reversed this effect (Fig. 4D). To confirm the receptor
specificity, the expression of these genes was com-
pared in LXR WT and KO mouse cultured keratino-
cytes and whole skin. The expression of Lass4,
Smpd1, Smpd2, and Smpdl3b was significantly de-
creased in LXR KO keratinocyte (Fig. 4E) and skin
samples (Fig. 4F), demonstrating that LASS and
SMPDs are novel LXR-dependent genes.
LXR-Null Mouse Is a Model of Human Aged Skin
The effect of LXR ligand on the expression of genes
involved in keratinocyte differentiation and barrier for-
mation prompted us to examine the consequences of
LXR ablation on mouse skin. LXR KO mice showed
reduced epidermal thickness due to decreased kera-
tinocyte proliferation (22). We compared LXR KO and
WT skin by transcription profiling using Affymetrix
GeneChip arrays. Pathway analysis using a modified
version of the sigpath algorithm (35) was used to
identify significantly regulated gene sets between
LXR KO and WT mouse skin. This analysis revealed
a striking resemblance with a previously described
gene expression pattern of young vs. aged human



































































































Fig. 3. The Effect of T1317 on Markers of Keratinocyte Differentiation
A, The LXR ligand induces keratinocyte differentiation markers in NHEKs. The relative expression level of TGM1, IVL, LOR, and
FLG2 was measured by real-time RT-PCR. B, The relative expression of epidermal differentiation markers Ivl, Tgm3, and Tgm6
in LXR WT (white bars) and KO (black bars) mouse skin is presented. C and D, The effect of T1317 (1 M) on Tgm1, Tgm3, and
Tgm6 expression in LXR WT and KO keratinocytes was evaluated by quantitative RT-PCR. White bars represent cells with
vehicle treatment, and black bars show gene expression in T1317-treated (1 M) mouse keratinocytes. *, P  0.01; **, P  0.05
vs. vehicle or WT control as determined by Student’s t test.
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human skin also showed reduced expression in
LXR KO mouse skin (Fig. 5A), thus indicating that
LXR-null mouse is a potential model of chronolog-
ically aged human skin.
To further characterize the molecular changes in
LXR KO, we examined the expression of specific
genes associated with skin aging and cell senescence.
Because fibroblasts affect keratinocyte proliferation
and differentiation, and senescent fibroblasts exhibit
reduced cholesterol efflux (37), the expression level of
genes involved in lipid efflux/transport was compared
in LXR WT and KO fibroblasts. Despite the presence
of LXR, the basal expression of lipid transporters
(Abca1 and Abcg1) and cholesterol binding proteins
(Apod and Apoe) was reduced in LXR-null fibroblasts
(Fig. 5B), indicating that KO fibroblasts may exhibit
the senescent phenotype because of reduced cho-
lesterol clearance, which is observed in Werner syn-
drome (human premature aging disorder) fibroblasts
(37). Increased COX-2 expression and PGE2 syn-
thesis are reported in photoaged and chronologi-
cally aged skin (12), and PGE2 has been linked to
replicative senescence in fibroblasts (10). Therefore,
we next compared the expression of COX-2 (Ptgs2)
in LXR WT and KO fibroblasts. As shown in Fig. 5B,
Ptgs2 expression was significantly up-regulated in
LXR-null fibroblasts, suggesting that LXR ligands
may reverse aging-associated fibroblast senes-
cence. In addition, the expression of MMP2 and
MMP9 was also induced in LXR KO skin (Fig. 2E),
a feature shared with both photoaged and chrono-
logically aged skin (2, 38). Taken together, these
results indicate LXR-null mouse as a model of hu-
















































































































































































Fig. 4. T1317 Induces the Expression of Lipid Synthesis and Transport Genes in Keratinocytes
A, The relative expression of genes involved in fatty acid synthesis (black bars), cholesterol binding (gray bars), and lipid
transport (white bars) after treatment of NHEKs with T1317 (1 M) was measured by real-time PCR. B, The effect of T1317 (1 M)
on the relative gene expression levels of Abcg1 and Scd1 in ex vivo cultured LXR WT and KO mice epidermal cells is presented.
White and black bars represent the relative gene expression levels in vehicle and T1317-treated keratinocytes, respectively. C,
A schematic representation of ceramide biosynthetic pathway and the enzymes involved is shown. D, The effect of T1317 (1 M)
treatment (24 h) on the expression of LASS4, SMPD2, and SMPDL3B in NHEKs with or without UVB exposure (8 mJ/cm2) as
measured by real-time RT-PCR is shown. Vehicle- and T1317-treated groups are shown as white and black bars, respectively.
E and F, The relative expression of Lass4, Smpd1, Smpd2, and Smpdl3b in LXR WT (white bars) and KO (black bars) in mouse
keratinocytes (E) and whole skin (F) is shown as measured by real-time RT-PCR, normalized to 18S RNA gene. *, P  0.01; **,
P  0.05 vs. vehicle or WT control as determined by Student’s t test.
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LXR Ligand Inhibits UV-Induced Skin Thickening
and Wrinkle Formation in Vivo
We next examined whether the molecular changes
induced by the LXR ligand can indeed influence the
appearance of photoaged skin in an animal model.
Therefore, the effect of T1317 was examined on UV-
induced skin thickening and wrinkle formation in a
hairless albino mouse model (39). UV radiation re-
sulted in a time-dependent increase in skin thickness
at wk 2, 4, and 6 in UV-exposed, vehicle-treated mice
compared with the mock-exposed groups (Fig. 6A).
Topical treatment with T1317 significantly reduced
UV-induced abnormal skin thickness in a dose-depen-
dent manner, and T1317 at 10 mM concentration did
not show any statistically significant (P  0.05) differ-
ence in skin thickness between the UV-exposed (UV)
and mock-exposed (UV) groups (Fig. 6A). UV expo-
sure of hairless mice for 6 wk also resulted in the
appearance of prominent wrinkles in vehicle-treated
group in comparison with mock-exposed groups, as
shown by silicon rubber replicas of the mouse dorsal
skin (Fig. 6B). Quantitation by replica scans showed
an increase in wrinkle score in the UV-exposed,
vehicle-treated group (Fig. 6C). Remarkably, a sig-
nificant decrease in wrinkle score was observed at
all three doses of the LXR ligand (Fig. 6, B and C). At
both 1 and 10 mM concentrations, the wrinkle scores
in UV groups were not significantly different (P 
0.05) from the UV groups (Fig. 6C). The results
from this murine model of photoaging indicate that
the LXR ligand indeed inhibits the signs of photo-
damage in vivo.
DISCUSSION
This study provides the first evidence demonstrating
LXR as a potential therapeutic target for the prevention
and treatment of photoaging and chronological skin
aging. LXR ligands may show efficacy in these indica-
tions because T1317 1) reduced the expression of
cytokines and metalloproteinases in UV-activated epi-
dermal keratinocytes and TNF-activated dermal fi-
broblasts, 2) increased the expression of keratinocyte
differentiation markers, 3) increased the expression of
genes required for fatty acid synthesis in keratino-
cytes, 4) increased the expression of cholesterol bind-
ing proteins and lipid transporters in skin cells and 5)
increased the expression of enzymes involved in cer-
amide synthesis in keratinocytes.
Fueled by an increase in the aging population, de-
mand for products and procedures that mitigate the
signs of skin aging has increased considerably in re-
cent years. Baby-boomers are demanding products
not only to maintain youthful appearance but also to
reverse age-related changes. Skin aging is a result of
the superposition of two biological processes, chro-
nological aging and photoaging. Currently, there are
no prescription treatments for chronologically aged
skin, whereas retinoids are the only class of topical
prescription agents approved for treating photodam-
aged skin (40). However, retinoid use is associated
with local side effects, such as irritation, erythema,
dryness, burning, scaling, and pruritis (40). These
properties may further exacerbate the dryness and
scaling associated with chronologically aged skin and































Fig. 5. Molecular Defects in LXR KO Skin
A, The relative mRNA expression of a gene set in mouse LXR WT (n 2) and KO (n 3) skin identified as regulated in human
old age skin compared with human young skin (36). Each lane represents gene set data obtained from one mouse skin sample.
The data are visualized in Spotfire 8.0. Each gene is z-scored, normalized, and color-coded (red, relatively high expression; white,
median expression; blue, low expression). B, The relative expression of Abca1, Abcg1, Apod, Apoe, and Cox-2 was measured
by real-time PCR in LXR WT (white bars) and KO (black bars) dermal fibroblasts obtained from mice pups. *, P  0.01 vs. WT
control as determined by Student’s t test.
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modalities, such as botulinum toxins and hyaluronic
acid fillers, are painful, invasive, and expensive. Thus,
there is an unmet need for agents that are safe and
efficacious for both photodamaged and chronologi-
cally aged skin. Human skin expresses a number of
NRs (RARs, VDR, glucocorticoid receptor, PPARs,
etc.), and their ligands (retinoids, vitamin D com-
pounds, glucocorticoids, etc.) are important regulators
of dermal physiology and pathology. Retinoids func-
tion in photoaging, psoriasis, and acne thorough RARs
that are expressed in skin (41). Natural and synthetic
VDR ligands are used in clinics for the treatment of
psoriasis, and glucocorticoids are the treatment of
choice for dermal inflammatory indications (41, 42).
The emerging biology of PPARs and LXRs in inhibiting
cutaneous inflammation and enhancing epidermal
barrier function suggests their ligands as potential
therapeutics for various dermal indications (21–23, 34,
43, 44).
The etiology of photoaging involves UV insult on
keratinocytes, resulting in the expression of NF-B-
responsive cytokines that activate fibroblasts and also
mediate the recruitment of neutrophils to the dermis
(3, 4, 45). Cytokine-activated fibroblasts and neutro-
phils secrete NF-B and AP-1-dependent MMPs
(MMP1, -2, -3, and -9), which degrade the dermal
matrix of collagen and elastin. Notably, LXR agonists
inhibit NF-B-mediated gene expression, implicating
LXR-NF-B cross talk as the central basis for their
antiinflammatory activity in macrophage systems (46).
Therefore, the LXR ligand appears to attenuate cyto-
kine and MMP expression in activated skin cells and
may mediate its efficacy in models of photoaging via
antagonism of NF-B-dependent gene expression. In
support of this notion, the NF-B pathway has also
been validated as a target for photodamage because
a specific pharmacological inhibitor, parthanolide, ex-
hibited efficacy in a murine model of photoaging (45).
Interestingly, both UV and cytokine exposures re-
sulted in the attenuation of LXR signaling pathway in
skin cells (Fig. 1, D–F), suggesting that the down-
modulation of LXR-responsive genes may also con-
tribute to the etiology of photoaging. Accordingly, ac-
tivation of LXRs by a specific agonist improved
photodamage and wrinkle formation in a murine model
of photoaging (Fig. 6, A–C). Increased expression of
Fig. 6. Topical Application of T1317 Shows Efficacy in a Murine Model of Photoaging
A, A time-course of UV radiation effect on hairless mouse skin thickness and the effect of various concentrations (0.1, 1, and
10 mM) of T1317 on skin thickness after 0, 2, 4, and 6 wk of topical treatment is shown. The mice were either mock irradiated
or exposed to UV radiation three times a week. The UV dose was increased weekly by 1 MED (1 MED  100 mJ/cm2) to a
maximum of 4 MED and subsequently maintained at this level for the remainder of the study period (39). Thickness of the dorsal
skin was measured using a caliper at baseline (wk 0) and after 2, 4, and 6 wk of UV exposure. The values are the mean of a total
of eight mice per group. B and C, Wrinkle formation was assessed after 6 wk UV exposure by preparing skin replicas (B) and
measured quantitatively by computer scanning of the replicas (C). Representative photographs taken at wk 6 are shown. Values represent
the mean  SEM (n  5). a, Groups that were statistically significantly different (P  0.05) from those labeled b; b, groups that were not
significantly different (P  0.05) from each other.
2414 Mol Endocrinol, November 2008, 22(11):2407–2419 Chang et al. • LXR as Therapeutic Target for Skin Aging
 at Seoul Natl Univ Central Library Periodicals Rm on December 23, 2009 mend.endojournals.orgDownloaded from 
MMPs is a common mechanism underlying the eti-
ology of both photoaging and chronological skin
aging. In both forms of aging, the dermis becomes
thin because of increased collagen degradation due
to elevated fibroblast MMP production and a con-
comitant decrease in TIMP-1 and collagen expres-
sion as a result of cell senescence (47, 48). There-
fore, LXR agonist may also show efficacy in
chronologically aged skin by reducing MMPs and
increasing TIMP-1 expression in dermal fibroblasts.
Cutaneous inflammation is also widely accepted as
an etiology of chronological skin aging (49), and a
molecular level proof-of-concept was provided by a
recent report that identified NF-B as the major
motif associated with aging (50). Adler et al. (50)
showed that inducible genetic blockade of NF-B
signaling for just 2 wk reversed the gene expression
profile of chronologically aged murine epidermis to
that of the young mice, suggesting that inhibition of
NF-B-dependent gene expression in the epidermis
could not only prevent but also reverse skin aging.
Therefore, LXR ligand may show efficacy in chrono-
logically aged skin via its anti-NF-B activity.
Xerosis or dry skin is the foremost uncomfortable
manifestation of the chronologically aged skin,
which occurs as a result of reduced lipid synthesis.
Interestingly, sphingolipids, fatty acids, and choles-
terol content of the aged skin is significantly re-
duced in comparison with young human and murine
skin, leading to defective barrier repair (7, 28, 29).
Because skin dehydration is one of the most com-
mon causes of fine skin wrinkling (51), the enhance-
ment of epidermal barrier function via increased cor-
neocyte differentiation and keratinocyte lipid
generation may contribute to prevention of transepi-
dermal water loss and improvement in skin wrinkling
(11). Topical application of LXR ligands inhibited
transepidermal water loss and stimulated the syn-
thesis of epidermal cholesterol, fatty acids, and
sphingolipids in hairless mouse (23). T1317 also in-
duced the expression of keratinocyte enzymes in-
volved in ceramide biosynthetic pathway (Fig. 4, D
and E). The identification of LASS4, SMPD1,
SMPD2, and SMPDL3b as newly identified LXR-
responsive genes (Fig. 4, D and E) provides a mo-
lecular basis for the LXR ligand-mediated increase
in sphingolipid synthesis in vivo (23). LXR ligands
may also increase lipid loading into the lamellar
bodies by inducing the expression of lipid binding
proteins and ABC transporter family members re-
quired for cholesterol and lipid efflux (Fig. 4, A and
B). In accordance, LXR ligands are documented to
induce the expression of lipid synthesis, binding,
and transport genes in liver, macrophage, and mi-
croglial systems (16, 19). Furthermore, LXR ligands
also induced the expression of ABCA1 in human
keratinocytes and murine epidermis (25). Therefore,
LXR ligands may exhibit a potent antixerosis thera-
peutic effect, thus alleviating one of the major symp-
toms of aged skin that leads to the deterioration of
epidermal barrier function and initiation of other se-
rious cutaneous conditions, e.g. dermatitis/eczema,
which is observed at an increasing incidence with
advancing age (52). Furthermore, we have identified
two new members of the ABC family, namely,
ABCA2 and ABCA13, that show LXR-dependent in-
crease in their expression in keratinocytes (Fig. 4A).
However, whether these transporters are localized
on the lamellar bodies and the identity of lipids that
ABCA2, ABCA12, and ABCA13 transport are open
questions and need to be answered to fully under-
stand the LXR mechanism of action in lipid transport
and lamellar body loading.
There is a defect in keratinocyte terminal differenti-
ation in aged skin. Oxysterols increase cornified en-
velope formation and the expression of TGM1 and IVL
in keratinocytes (31), and the enhanced expression of
IVL has been attributed to the induction of Jun/Fos
family members (26, 31). Here, we demonstrate that
TGM1, IVL, LOR, and FLG are LXR-responsive genes
in NHEKs because their expression was induced by
T1317 (Fig. 3A). Tgm1, Tgm3, Tgm6, and Ivl are plau-
sibly direct LXR-responsive genes because their ex-
pression was decreased in LXR KO mouse skin (Fig.
3B). LXR-mediated induction of AP-1-responsive LOR
and FLG expression might be secondary to enhanced
keratinocyte differentiation and/or increased choles-
terol sulfate-protein kinase C n signaling via induction
of cholesterol sulfotransferase expression (43). There-
fore, LXR ligands may normalize the keratinocyte
terminal differentiation defect that is observed in the
aged epidermis (11).
Importantly, LXR-null mice showed epidermal thin-
ning because of decreased keratinocyte proliferation
(22), which is a phenotypic hallmark of chronologically
aged skin. Dermal fibroblasts also exhibit senescent
phenotype in chronological skin aging (10, 48). En-
hanced PGE2 production as well as COX activity has
been associated with the underlying pathology of var-
ious disorders of aging, such as atherosclerosis, ar-
thritis, autoimmunity, and cancer. Increased UV-me-
diated COX-2 expression is reported in aged human
skin, and it has been implicated to play a role in fibro-
blast senescence (10, 12). Augmentation of COX-2
activity in aged human skin assumes importance be-
cause PGE2 has been shown to inhibit collagen and
fibronectin synthesis and enhance MMP production in
fibroblasts (10). Importantly, a selective COX-2 inhib-
itor reduced senescence-associated PGE2 production
and COX-2, p53, and MMP-1 expression and en-
hanced the expression of TIMP-1 and procollagen in
dermal fibroblasts (10). Interestingly, COX-2 expres-
sion was up-regulated in LXR KO fibroblasts (Fig.
5B), indicating a molecular similarity between LXR-
null mouse and human aged skin fibroblasts. There-
fore, LXR ligands may also impact the process of skin
aging by inhibiting the negative consequences of in-
creased PGE2 via down-regulating the expression of
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COX-2 in fibroblasts. Dermal fibroblasts from Werner
syndrome, a human premature aging disorder, pa-
tients show an early onset of senescent phenotype,
which has been linked to defective cholesterol efflux
and intracellular lipid transport (37). LXR-null fibro-
blasts demonstrated decreased expression of choles-
terol efflux and binding proteins, thus indicating that
LXR ligands may reverse aging-associated fibroblast
senescence by normalizing lipid homeostasis (Fig.
5B). Decreased expression of lipid transport proteins
in LXR KO mice and Werner syndrome fibroblasts
may result in not only increased intracellular lipid ac-
cumulation but also enhanced UVA-induced lipid per-
oxidation, which is observed in skin aging (14). Signif-
icantly, transcriptional profiling of LXR KO vs. WT
skin showed similar regulation of a subset of genes
(Fig. 5A) with a previously described transcriptional
profiling study comparing human aged vs. young skin
(36), further corroborating LXR KO to be a model of
human aged skin at both phenotypic and molecular
levels.
In the past century, medical advances have gradu-
ally augmented the average life expectancy through-
out the world, which in turn has increased the human
desire to remain youthful. Because the face plays an
important role in our daily communications, it is cur-
rently the focus of anti-skin aging cosmaceuticals and
therapeutics. The clinical development of potent and
efficacious products for the face is likely to spur re-
search for the identification of safe compounds for the
thickening and restoration of the whole body skin, i.e.
an efficacious agent for skin fragility, bedsores, and
other less understood and intractable ailments of the
aged skin. Currently, we are at an early stage of skin
anti-aging research, and understanding the mecha-
nism of action of therapeutically effective facial agents
will help in our efforts to identify novel molecules to
rejuvenate aged senescent keratinocytes and fibro-
blasts, which may pave the way for the identification of
agents that increase the lifespan by reversing the
clock for multiple cell types and tissues.
MATERIALS AND METHODS
Skin Cells and Cell Culture Conditions
NHEKs and NHDFs (Cambrex/Lanza, Walkersville, MD) and
human dermal fibroblasts cell lines HFF and BJ-5ta (Ameri-
can Type Culture Collection, Rockville, MD) were cultured as
per vendors’ recommendations. In general, cells were
trypsinized and seeded on d 0, T1317 treatments (0.4 or 1 M)
were done on d 1 with and without UV (8 mJ/cm2) or TNF (1
ng/ml) activations, and cells were harvested on d 2 with lysis
buffer (Applied Biosystems/Ambion, Foster City, CA) directly
added to the cultured cells after a PBS wash. Cells were
either used for RNA purification using QIAGEN RNeasy RNA
purification column (QIAGEN, Hilden, Germany) as per ven-
dor’s protocol or directly processed to cDNA using Cell-to-
cDNA lysis buffer (Ambion, Foster City, CA).
Expression Profiling
The expression of LXR and - was interrogated in various
tissues by in silico mining of Wyeth Research database of
Human Genome U133 Plus 2.0 transcriptional profiling data
from 33 normal human tissues. The data were acquired from
a source generated by Gene Logic (Gaithersburg, MD) and
Wyeth Research (Cambridge, MA) using standardized proce-
dures and internal controls to minimize variation. Each tissue
consisted of at least six replicas. All transcriptional profiling
data were normalized to a mean signal intensity value of 100
in GCOS (Affymetrix, Santa Clara, CA).
Microarray Processing
Five micrograms of total RNA from whole skin section of
LXR KO and WT animals were used to generate biotin-
labeled cRNA using an oligo T7 primer in a reverse transcrip-
tion reaction followed by in vitro transcription reaction with
biotin-labeled UTP and CTP. Ten micrograms of cRNA were
fragmented and hybridized to MOE430 2.0 arrays (Af-
fymetrix). Statistical identification of significantly regulated
biological pathways was implemented using a modified ap-
proach (35).
LXR WT and KO Skin Cell Preparations
LXR- KO mice were obtained from Deltagen (San Carlos,
CA) in the 129 strain and backcrossed for seven generations
into black C57BL/6J mice. LXR- KO was accomplished
using LXR- gene sequence deletion from bases 226–395 by
using a homologous recombination vector (Deltagen). Skins
from newborn mice (2–3 d old) were isolated and floated on
2.5 mg/ml dispase (Invitrogen/GIBCO, Carlsbad, CA) over-
night at 4 C and separated into epidermal and dermal layers
using small forceps. The epidermal and dermal layers were
minced and subjected to several differential centrifugations,
fractionations, and filtrations as previously described (53).
These cells were then cultured in Eagle’s MEM containing
fetal bovine serum (8%) in 24-well culture plates (d 0). Cells
were treated with vehicle or T1317 on d 2, followed by iso-
lation and purification of RNA on d 3 using RNeasy column
(QIAGEN). Gene expression profiles were analyzed using
TaqMan low-density array (TLDA) and individual TaqMan
gene assays (Applied Biosystems, Foster City, CA).
Custom-Designed TLDAs and Quantitative RT-PCR
The RNA or cDNA obtained from the compound-treated cells
were used in custom-designed TLDAs or individual TaqMan
assays (Applied Biosystems) as per vendor’s protocols using
ABI 7900HT real-time PCR machine. The level of expression
was calculated based on the PCR cycle number (Ct), and the
relative gene expression level was determined using the
Ct method as described elsewhere (54). One TLDA was
designed with oligo probes and primer pairs for TNF (Applied
Biosystems assay ID Hs00174128_m1), IL-1B (Hs00174097_
m1), IL-6 (Hs00174131_m1), IL-8 (Hs00174103_m1), MMP1
(Hs00233958_m1), MMP3 (Hs00233962_m1), MMP9
(Hs00234579_m1), TIMP1 (Hs00171558_m1), DCN (Hs00754870_
s1), COL1A1 (Hs00164004_m1), CCL3 (Hs00234142_m1),
CCL4 (Hs99999148_m1), CCL5 (Hs00174575_m1), NOS2A
(Hs00167257_m1), PTGS2 (Hs00153133_m1), and 18S
(Hs99999901_s1) control gene. The second TLDA contained
oligo probes and primer pairs for known LXR-responsive genes
as well as some other genes of interest. It contained probes
and primer pairs for ACACA (Hs00167385_m1), ACAT2
(Hs00255067_m1),APOD(Hs00155794_m1),APOE(Hs00171168_
m1), FASN (Hs00188012_m1), FDFT1 (Hs00189506_m1),
FOXM1 (Hs00153543_m1), LDLR (Hs00181192_m1),
NPC1L1 (Hs00203602_m1), NR1H2 (Hs00173195_m1), NR1H3
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(Hs00172885_m1),PLTP(Hs00272126_m1),SCD(Hs00748952_
s1), SLC2A4 (Hs00168966_m1), SREBF1 (Hs00231674_
m1), SREBF2 (Hs00190237_m1), STAR (Hs00264912_m1),
ABCA1 (Hs00194045_m1), ABCA2 (Hs00242232_
m1), ABCA13 (Hs00541549_m1), ABCG1 (Hs00245154_
m1), ABCA12 (Hs00292421_m1), ADMTS4 (Hs00192708_m1),
CYP11A1 (Hs00167984_m1), PTGES (Hs00610420_m1),
MMP1 (Hs00233958_m1), and housekeeping genes GAPDH
(Hs00266705_g1) and 18S (Hs99999901_s1). Some of these indi-
vidual gene assays from the list above (identical assay ID) were also
purchased from Applied Biosystems and used for confirmation or
focused assay purposes. Other gene assays used in this study
included human genes LASS2 (Hs00604577_m1), LASS4
(Hs01001661_m1), SMPD1 (Hs00609415_m1), SMPD2
(Hs00162006_m1), SMPDL3B (Hs00205522_m1),
TGM1 (Hs00165929_m1), IVL (Hs00846307_s1), LOR
(Hs01894962_s1), and FLG2 (Hs00418578_m1) and mouse
genes Abcg1 (Mm00437390_m1), Abca1 (Mm00442646_
m1), Scd1 (Mm00772290_m1), Mmp2 (Mm00439508_m1), Mmp3
(Mm00440295_m1), Mmp9 (Mm00442991_m1), Mmp13
(Mm00439491_m1),Il1b(Mm00434228_m1),Tgm1(Mm00498375_
m1), Tgm3 (Mm00436999_m1), Tgm6 (Mm00624922_m1),
Ivl (Mm00515219_s1), Smpd1 (Mm00488318_m1), Smpd2
(Mm00486247_m1), Smpdl3b (Mm00505696_m1), and Lass4
(Mm00482658_m1).
Murine Model of Photoaging
Five-week-old female albino hairless mice (Hos:HR-1) were
obtained from the HOSHINO Laboratory Animals (HOS, Ko-
toh-cho, Japan). Animals had free access to food and water
and were acclimated for 1 wk before the study. Eight mice
were allocated to each group (total six groups for each test
compound). All experimental protocols were approved by
Institutional Animal Care and Use Committee of Clinical Re-
search Institute, Seoul National University Hospital (Associ-
ation for Assessment and Accreditation of Laboratory Animal
Care accredited facility). An UV irradiation device that included
TL20W/12RS UV lamps (Philips, Eindhoven, The Netherlands)
with an emission spectrum between 275 and 380 nm (peak,
310–315 nm), served as the UV source. A Kodacel filter (TA401/
407; Kodak, Rochester, NY) was mounted 2 cm in front of the
UV lamp to remove wavelengths of less than 290 nm (UVC).
Irradiation intensity at the mouse skin surface was mea-
sured using an UV meter (model 585100; Waldmann Co.,
Villigen-Schwenigen, Germany). The irradiation intensity
20 cm from the light source was 0.5 mW/cm2.
Initially, we measured the minimal erythma dose (MED) on
dorsal skin of mice. MED can be defined as the minimum
amount of radiation exposure required to produce an
erythma with sharp margins after 48 h. Mice were exposed to
UV light three times per week (Monday, Wednesday, and
Friday) for 6 wk. The irradiation dose was increased weekly
by 1 MED (1 MED  100 mJ/cm2) up to 4 MED and then
maintained at 4 MED. UV irradiation was stopped after irra-
diation for the sixth week. T1317 or its vehicle (70% ethanol,
30% polyethylene glycol) was topically applied to the dorsal
area (50 l) after each exposure to UV irradiation (five times
per week). Dorsal skin-fold thickness was measured using a
caliper (Peacock; Ozaki MFG Co. Ltd., Tokyo, Japan). Skin
thickness was measured on wk 0, 2, 4, and 6. Skin wrinkle
replicas were obtained with a silicon rubber (Silflo dental
impression material; Flexico Developments, Potters Bar, UK)
to the backs of unstrained mice. Skin impressions were pho-
tographed using a coupling charge system (CCD) video cam-
era and analyzed by Skin-Visiometer SV 600 software (CK
Electronic GmbH, Köln, Germany).
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